Renal & Urology

Hypokalaemia

Hypokalaemia is a serum potassium below 3.5 mmol/L, usually from gastrointestinal or renal loss or a transcellular shift; assess the ECG and symptoms urgently, replace potassium safely, correct magnesium and treat the cause.

In a nutshell

Hypokalaemia is serum potassium below 3.5 mmol/L. Think loss or intracellular shift, check magnesium and ECG, and treat severity, symptoms and cause together. Oral potassium is preferred when safe; severe or symptomatic disease, ECG changes or inability to absorb usually needs monitored IV replacement under current BNF/local policy.

Classic presentation

A patient taking a thiazide has weakness and palpitations, a potassium of 2.7 mmol/L, low magnesium and U waves: monitor, replace potassium and magnesium safely, and review the diuretic and cause.

Key points

  • The ECG may be normal despite clinically important hypokalaemia; assess it alongside symptoms and risk.
  • Low magnesium can make potassium replacement ineffective.
  • Use oral potassium when the patient can swallow and absorb it; reserve IV replacement for severe, symptomatic or non-enteral situations.
  • Never give concentrated IV potassium as a rapid bolus; use a prepared infusion, pump and the current local/BNF protocol.
  • In DKA, potassium can fall rapidly after insulin starts, so follow the relevant NICE protocol and monitor frequently.
  • Hypokalaemic cardiac arrest has a separate Resuscitation Council UK emergency algorithm.

First-line investigation

Repeat serum potassium with U&E, renal function, magnesium and acid-base assessment, plus a 12-lead ECG.

Management

Assess cardiac and neuromuscular risk

  • Urgently escalate severe, symptomatic or ECG-positive hypokalaemia, arrhythmia, weakness with respiratory involvement, renal impairment or rapidly falling potassium for monitored replacement.1,4

Confirm and classify the cause

  • Repeat potassium, measure magnesium and renal function, obtain an ECG, and use the history, medication review, acid-base status and urinary potassium when the cause is unclear.1,3,7

Replace potassium safely

  • Use oral replacement when safe; use prepared, glucose-free IV potassium under current BNF/local safeguards when severe, symptomatic or unable to absorb. Correct magnesium concurrently and monitor potassium, magnesium, renal function and ECG as indicated.1,4,2

Treat the cause and prevent recurrence

  • Review diuretics and other medicines, treat gastrointestinal losses, follow DKA or refeeding protocols where relevant, and seek renal/endocrine input for persistent, recurrent or hypertensive hypokalaemia.5,10,3,8

Exam traps

  • Always check magnesium when hypokalaemia is unexplained or resistant.
  • IV potassium is a high-risk medicine: use a prepared infusion and never give a concentrated rapid bolus.
  • A low potassium during DKA is a treatment emergency because insulin can drive it lower.
  • Hypokalaemia plus hypertension suggests a renal or mineralocorticoid cause, not simply poor dietary intake.
  • Do not use the cardiac-arrest potassium regimen for routine ward replacement.
  • In renal impairment or oliguria, standard replacement can cause dangerous hyperkalaemia.

Illustrations

ECG changes in hypokalaemiaAn ECG strip showing flattened T waves, ST depression and prominent U waves after the T wave, the characteristic pattern of hypokalaemia.James Heilman, MD, Wikimedia Commons · CC-BY-SA-3.0

Key sources

  1. NHS Specialist Pharmacy Service, Treating acute hypokalaemia in adults (Current UK professional medicines guidance covering severity bands, oral and IV replacement, concentration and rate safeguards, and monitoring; published 14 August 2024)Published 14 Aug 2024
  2. BNF, potassium chloride and potassium replacement (Current BNF prescribing monographs for oral and intravenous potassium; direct monograph access may require an NHS login, so dosing must be checked in the live BNF and local medicines policy)
  3. Royal United Hospitals Bath, Hypokalaemia: a guide for GPs (UK NHS laboratory guidance on cause-directed assessment, magnesium, oral replacement and specialist advice; version 3.1 issued 19 November 2024)Published 19 Nov 2024
  4. Resuscitation Council UK, 2025 Special circumstances guidelines (Current UK resuscitation guidance for hypokalaemia, including concurrent magnesium correction and the hypokalaemic cardiac-arrest pathway; published 2025)Published 27 Oct 2025
  5. NICE NG17, Type 1 diabetes in adults: diagnosis and management (Current adult DKA recommendations including early potassium replacement and frequent monitoring; accessed 4 August 2026)
  6. NICE CG174, Intravenous fluid therapy in adults in hospital (Current NICE principles for IV-fluid assessment, electrolyte replacement, monitoring and specialist help in complex electrolyte imbalance; published 10 December 2013)Published 10 Dec 2013
  7. Royal United Hospitals Bath Pathology Services, Potassium interpretation (Current UK NHS laboratory advice on urgent severe or symptomatic hypokalaemia and urinary potassium interpretation; page updated 16 December 2025)Published 16 Dec 2025
  8. NICE NG136, Hypertension in adults: diagnosis and management (Current NICE hypertension guidance supporting cause-directed assessment when hypokalaemia and hypertension suggest secondary hypertension)Published 28 Aug 2019
  9. BNF, magnesium replacement (Current BNF magnesium prescribing monographs for route, dose and renal-adjustment decisions; check the live monograph and local protocol)
  10. NICE NG18, Diabetes in children and young people: diagnosis and management (Current paediatric DKA recommendations including potassium-containing fluids and urgent specialist discussion for hypokalaemia; accessed 4 August 2026)

This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.